Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients

BACKGROUND: Current fertility preservation strategies for young breast cancer patients planning a future motherhood include the association of controlled ovarian stimulation with the aromatase inhibitor letrozole (let-COS) to harvest mature oocytes while maintaining low estradiol levels. Despite thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothé, Françoise, Lambertini, Matteo, Goldrat, Oranite, Maetens, Marion, Bareche, Yacine, Blanc, Jeremy, Rouas, Ghizlane, Larsimont, Denis, Sotiriou, Christos, Ignatiadis, Michail, Demeestere, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370091/
https://www.ncbi.nlm.nih.gov/pubmed/34414109
http://dx.doi.org/10.3389/fonc.2021.686625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370091/
https://www.ncbi.nlm.nih.gov/pubmed/34414109
http://dx.doi.org/10.3389/fonc.2021.686625

Ejemplares similares